Rankings
▼
Calendar
NMRA (Neumora Therapeutics, Inc. Common Stock) Stock Financials & Earnings | Market Cap Arena
NMRA
Neumora Therapeutics, Inc. Common Stock
Mkt Cap
$586M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$236M
EPS (TTM)
-$1.47
Free Cash Flow (TTM)
-$209M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 16
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$31M
Q1 23
$0
$0
-$39M
Q2 23
$0
$0
-$42M
Q3 23
$0
$0
-$57M
Q4 23
$0
-$166K
-$50M
Q1 24
$0
$0
-$60M
Q2 24
$0
$0
-$64M
Q3 24
$0
$0
-$77M
Q4 24
$0
$0
-$63M
Q1 25
$0
$0
-$71M
Q2 25
$0
$0
-$54M
Q3 25
$0
-$5M
-$58M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$30M
-$30M
Q1 23
-$33M
-$33M
Q2 23
-$31M
-$31M
Q3 23
-$48M
-$48M
Q4 23
-$51M
-$51M
Q1 24
-$43M
-$43M
Q2 24
-$56M
-$56M
Q3 24
-$33M
-$33M
Q4 24
-$50M
-$50M
Q1 25
-$59M
-$59M
Q2 25
-$52M
-$52M
Q3 25
-$47M
-$47M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$23K
Q1 23
$36K
Q2 23
$0
Q3 23
$37K
Q4 23
$44K
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
—
+15.7%
Q1 23
—
-9.4%
Q2 23
—
+34.3%
Q3 23
—
+85.8%
Q4 23
—
+63.1%
Q1 24
—
+53.4%
Q2 24
—
+51.7%
Q3 24
—
+34.8%
Q4 24
—
+25.6%
Q1 25
—
+18.1%
Q2 25
—
-15.3%
Q3 25
—
-24.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$3M
—
Q1 23
$2M
—
Q2 23
$0
—
Q3 23
$6M
—
Q4 23
$6M
—
Q1 24
$7M
—
Q2 24
$13M
—
Q3 24
$10M
—
Q4 24
$10M
—
Q1 25
$9M
—
Q2 25
$7M
—
Q3 25
$6M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q4 22
$24M
$7M
—
Q1 23
$29M
$10M
—
Q2 23
$33M
$9M
—
Q3 23
$42M
$15M
—
Q4 23
$39M
—
$11M
Q1 24
$46M
$14M
—
Q2 24
$49M
$15M
—
Q3 24
$61M
$16M
—
Q4 24
$46M
$17M
—
Q1 25
$52M
$19M
—
Q2 25
$39M
$15M
—
Q3 25
$41M
$12M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$241M
$131M
$372M
Q1 23
$211M
$135M
$346M
Q2 23
$204M
$120M
$324M
Q3 23
$412M
$97M
$510M
Q4 23
$374M
$80M
$454M
Q1 24
$183M
$240M
$423M
Q2 24
$151M
$221M
$372M
Q3 24
$276M
$66M
$341M
Q4 24
$142M
$165M
$308M
Q1 25
$127M
$122M
$249M
Q2 25
$125M
$93M
$218M
Q3 25
$129M
$42M
$172M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
152M
+0.0%
Q1 23
152M
+0.0%
Q2 23
152M
+0.0%
Q3 23
155M
+2.3%
Q4 23
159M
+2.2%
Q1 24
158M
-0.6%
Q2 24
159M
+0.7%
Q3 24
160M
+0.4%
Q4 24
161M
+0.9%
Q1 25
161M
+0.3%
Q2 25
162M
+0.1%
Q3 25
162M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
$0
124
FY 24
$0
110
marketcaparena.com